Drugs / sublingual immunotherapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01127035 | Jan 2006 → Oct 2008 | allergic rhinitis | University of Genova | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sublingual immunotherapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01127035 ↗ |
| Known as | SLIT | “Sublingual immunotherapy (SLIT) is safe and effective, but data for Alternaria are lacking.” NCT01127035 ↗ |